Follow-up studies showed that suppression of VEGF reduced progression of retinal vessel closure and caused improvement in perfusion in some patients with retinal vein occlusion or diabetic macular edema (DME)25,26, and improved background diabetic retinopathy in patients with DME27. This evidence concerns the gene VEGFA and retinal vein occlusion.